HomenewsEconomicsFarallon Capital to Wage Proxy Battle at Biotech Firm

Farallon Capital to Wage Proxy Battle at Biotech Firm

  • April 4, 2023
  • Posted by: GMI-Co
  • Category: Economics
No Comments

Farallon has nominated three directors to the board of Exelixis, which develops cancer-fighting drugs.



Leave a Reply